Linked Life Data

2416012

Source:http://linkedlifedata.com/resource/pubmed/id/2416012

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2416012rdf:typepubmed:Citationlld:pubmed
pubmed-article:2416012lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:2416012lifeskim:mentionsumls-concept:C0003842lld:lifeskim
pubmed-article:2416012lifeskim:mentionsumls-concept:C0042449lld:lifeskim
pubmed-article:2416012lifeskim:mentionsumls-concept:C0028977lld:lifeskim
pubmed-article:2416012lifeskim:mentionsumls-concept:C0028351lld:lifeskim
pubmed-article:2416012lifeskim:mentionsumls-concept:C0021516lld:lifeskim
pubmed-article:2416012lifeskim:mentionsumls-concept:C0042395lld:lifeskim
pubmed-article:2416012lifeskim:mentionsumls-concept:C0027893lld:lifeskim
pubmed-article:2416012lifeskim:mentionsumls-concept:C0038585lld:lifeskim
pubmed-article:2416012lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:2416012lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:2416012lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:2416012lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:2416012lifeskim:mentionsumls-concept:C1519957lld:lifeskim
pubmed-article:2416012pubmed:issue1lld:pubmed
pubmed-article:2416012pubmed:dateCreated1986-1-14lld:pubmed
pubmed-article:2416012pubmed:abstractTextHuman omental arteries and veins are supplied with nerve fibers containing noradrenaline (NA) and neuropeptide Y (NPY); these two agents probably co-exist in perivascular sympathetic nerve fibers. Substance P (SP)- or vasoactive intestinal peptide (VIP)-containing fibers could not be detected. In studies on isolated omental vessels NA produced constriction. The results of blockade experiments suggest that human omental arteries are equipped predominantly with alpha 1-adrenoceptors and omental veins with a mixture of alpha 1- and alpha 2-adrenoceptors. NPY at a concentration of 10(-7) M or higher had a weak contractile effect on veins and virtually no effect on arteries. NPY at a concentration of 3 X 10(-8) M shifted the NA concentration response curve to the left in arteries (pD2 = 5.8 for NA versus 6.6. for NA in the presence of NPY; P less than 0.001) but not in veins. Both SP and VIP relaxed arteries precontracted with NA or prostaglandin F2 alpha (PGF2 alpha). The potency of SP as a relaxant agent was similar in arteries and veins; the effect of VIP was elicited at lower concentrations in veins than in arteries.lld:pubmed
pubmed-article:2416012pubmed:languageenglld:pubmed
pubmed-article:2416012pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2416012pubmed:citationSubsetIMlld:pubmed
pubmed-article:2416012pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2416012pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2416012pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2416012pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2416012pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2416012pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2416012pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2416012pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2416012pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2416012pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2416012pubmed:statusMEDLINElld:pubmed
pubmed-article:2416012pubmed:monthSeplld:pubmed
pubmed-article:2416012pubmed:issn0167-0115lld:pubmed
pubmed-article:2416012pubmed:authorpubmed-author:EdvinssonLLlld:pubmed
pubmed-article:2416012pubmed:authorpubmed-author:HåkansonRRlld:pubmed
pubmed-article:2416012pubmed:authorpubmed-author:SundlerFFlld:pubmed
pubmed-article:2416012pubmed:authorpubmed-author:UddmanRRlld:pubmed
pubmed-article:2416012pubmed:authorpubmed-author:SteenSSlld:pubmed
pubmed-article:2416012pubmed:authorpubmed-author:WahlestedtCClld:pubmed
pubmed-article:2416012pubmed:issnTypePrintlld:pubmed
pubmed-article:2416012pubmed:volume12lld:pubmed
pubmed-article:2416012pubmed:ownerNLMlld:pubmed
pubmed-article:2416012pubmed:authorsCompleteYlld:pubmed
pubmed-article:2416012pubmed:pagination67-79lld:pubmed
pubmed-article:2416012pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2416012pubmed:meshHeadingpubmed-meshheading:2416012-...lld:pubmed
pubmed-article:2416012pubmed:meshHeadingpubmed-meshheading:2416012-...lld:pubmed
pubmed-article:2416012pubmed:meshHeadingpubmed-meshheading:2416012-...lld:pubmed
pubmed-article:2416012pubmed:meshHeadingpubmed-meshheading:2416012-...lld:pubmed
pubmed-article:2416012pubmed:meshHeadingpubmed-meshheading:2416012-...lld:pubmed
pubmed-article:2416012pubmed:meshHeadingpubmed-meshheading:2416012-...lld:pubmed
pubmed-article:2416012pubmed:meshHeadingpubmed-meshheading:2416012-...lld:pubmed
pubmed-article:2416012pubmed:meshHeadingpubmed-meshheading:2416012-...lld:pubmed
pubmed-article:2416012pubmed:meshHeadingpubmed-meshheading:2416012-...lld:pubmed
pubmed-article:2416012pubmed:meshHeadingpubmed-meshheading:2416012-...lld:pubmed
pubmed-article:2416012pubmed:meshHeadingpubmed-meshheading:2416012-...lld:pubmed
pubmed-article:2416012pubmed:meshHeadingpubmed-meshheading:2416012-...lld:pubmed
pubmed-article:2416012pubmed:meshHeadingpubmed-meshheading:2416012-...lld:pubmed
pubmed-article:2416012pubmed:meshHeadingpubmed-meshheading:2416012-...lld:pubmed
pubmed-article:2416012pubmed:meshHeadingpubmed-meshheading:2416012-...lld:pubmed
pubmed-article:2416012pubmed:meshHeadingpubmed-meshheading:2416012-...lld:pubmed
pubmed-article:2416012pubmed:meshHeadingpubmed-meshheading:2416012-...lld:pubmed
pubmed-article:2416012pubmed:meshHeadingpubmed-meshheading:2416012-...lld:pubmed
pubmed-article:2416012pubmed:meshHeadingpubmed-meshheading:2416012-...lld:pubmed
pubmed-article:2416012pubmed:meshHeadingpubmed-meshheading:2416012-...lld:pubmed
pubmed-article:2416012pubmed:meshHeadingpubmed-meshheading:2416012-...lld:pubmed
pubmed-article:2416012pubmed:meshHeadingpubmed-meshheading:2416012-...lld:pubmed
pubmed-article:2416012pubmed:meshHeadingpubmed-meshheading:2416012-...lld:pubmed
pubmed-article:2416012pubmed:meshHeadingpubmed-meshheading:2416012-...lld:pubmed
pubmed-article:2416012pubmed:year1985lld:pubmed
pubmed-article:2416012pubmed:articleTitleInnervation of human omental arteries and veins and vasomotor response to noradrenaline, neuropeptide Y, substance P and vasoactive intestinal peptide.lld:pubmed
pubmed-article:2416012pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2416012pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:2416012pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed